ElectoroCore获得NeuroMetrix,用于扩大生物电子医药供应。 ElectroCore acquires NeuroMetrix for expanded bioelectronic medicine offerings.

ElectroCore是一家生物电子医学公司,正在收购一家医疗技术公司Neuro Metrix, 这笔交易预计将在2025年第一季度末终止。 ElectroCore, a bioelectronic medicine company, is acquiring NeuroMetrix, a medical tech firm, in a deal expected to close by the end of the first quarter of 2025. NeuroMetrix股东将获得现金和或有价值权利。 NeuroMetrix shareholders will receive cash and Contingent Value Rights. 收购的目的是扩大EmoteCore的产品范围和市场存在,特别是利用NeuroMetrix的治疗纤维分裂和慢性疼痛的Quell平台。 The acquisition aims to expand ElectroCore's product range and market presence, particularly with NeuroMetrix's Quell platform for treating fibromyalgia and chronic pain.